HK Stock Market Move | GENSCRIPT BIO (01548) fell more than 7%, and the overnight stock price of associated Legend Biotech dropped by over 11%.
Jinshi Biotechnology (01548) fell by more than 7%, as of the time of writing, it has fallen by 6.98%, to 13.07 Hong Kong dollars, with a turnover of 130 million Hong Kong dollars.
GENSCRIPT BIO (01548) fell more than 7%, as of the time of writing, it was down 6.98% at 13.07 Hong Kong dollars, with a turnover of 1.3 billion Hong Kong dollars.
On the news front, the overnight stock price of GENSCRIPT BIO's affiliate Legend Biotech fell by over 11%. On the evening of January 21, GENSCRIPT BIO announced that Legend Biotech disclosed that CARVYKTI had a net trade sales revenue of approximately 555 million US dollars for the fourth quarter ending December 31 of last year. The group stated that the net trade sales revenue was based on data provided by Johnson & Johnson to Legend, and both Legend and the group did not independently verify the accuracy of these sales figures. It is understood that CARVYKTI achieved sales of 1.332 billion US dollars in the first three quarters, with sales of 524 million US dollars in the third quarter.
Related Articles

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


